My bookmarksSign up free
Source

2010/30/: Commission Decision of 9 December 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 9703) (Text with EEA relevance)

2010/30/: Commission Decision of 9 December 2009 amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2009) 9703) (Text with EEA relevance)

Decision · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Decision 2008/911/EC is amended as follows: 1. Annex I is amended in accordance with Annex I to this Decision; 2. Annex II is amended in accordance with Annex II to this Decision.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I In Annex I to Decision 2008/911/EC, the following two substances are inserted after ‘ Calendula officinalis L.’: — ‘ Echinacea purpurea (L.) Moench’ — ‘ Eleutherococcus senticosus (Rupr. et Maxim.) Maxim’

ANNEX IISupplementary provisions

Open ↗

ANNEX II In Annex II to Decision 2008/911/EC, the following is inserted after the entry relating to ‘ Calendula officinalis L’: ‘ COMMUNITY LIST ENTRY ON ECHINACEA PURPUREA (L.) MOENCH, HERBA RECENS Scientific name of the plant Echinacea purpurea (L.) Moench Botanical family Asteraceae Herbal substance Purple coneflower herb Common name in all EU official languages of herbal substance   BG (bălgarski): пурпурна ехинацея, пресен стрък   CS (čeština): čerstvá nať třapatky nachové   DA (dansk): Purpursolhat, frisk urt   DE (Deutsch): Purpursonnenhutkraut, frisch   EL (elliniká): Πόα Εχινάκεας της πορφυράς   EN (English): purple coneflower herb   ES (español): Equinácea purpúrea, partes aéreas incluidas sumidades floridas   ET (eesti keel): punane siilkübar   FI (suomi): kaunopunahattu, tuore verso   FR (français): parties aériennes fraîches d’échinacée pourpre   HU (magyar): bíbor kasvirág virágos hajtása   IT (italiano): Echinacea purpurea, pianta fresca   LT (lietuvių kalba): rausvažiedžių ežiuolių žolė   LV (latviešu valoda): purpursarkanās ehinacejas laksti   MT (malti): Echinacea Vjola   NL (nederlands): rood zonnehoedkruid   PL (polski): jeżówka purpurowa, świeże ziele   PT (português): Equinácea, partes aéreas floridas   RO (română): iarbã proaspãtã de Echinacea, pãlãria soarelui   SK (slovenčina): echinacea purpurová, čerstvá vňať   SL (slovenščina): sveža zel škrlatne ehinaceje   SV (svenska): röd solhatt, färsk ört   IS (íslenska): Sólhattur   NO (norsk): Rød solhatt Herbal preparation(s) Expressed juice and dried expressed juice from fresh flowering aerial parts. European Pharmacopoeia monograph reference N/A Indication(s) Traditional herbal medicinal product for treatment of small superficial wounds. The product is a traditional herbal medicinal product for use in a specified indication exclusively based on long-standing use. Type of tradition European. Specified strength 10 to 20 g/100 g of expressed juice or equivalent amount of dried expressed juice in liquid or semi-solid dosage forms. Specified posology Adolescents over the age of 12 years, adults, elderly Small amount of ointment is applied on the affected area 2-3 times a day. The use in children under 12 years of age is not recommended (see below “Special warnings and precautions for use”). Route of administration Cutaneous use. Duration of use or any restrictions on the duration of use Do not use the medicinal product for more than 1 week. If the symptoms persist during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted. Any other information necessary for the safe use Contra-indications Hypersensitivity to the active substance or to plants of the Asteraceae (Compositae) family. Special warnings and precautions for use If signs of skin infection are observed, medical advice should be sought. The use in children below 12 years of age is not recommended because a safe use has not been sufficiently documented. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation There are no data on cutaneous use during pregnancy or lactation. Products containing Echinacea should not be applied to the breast of breastfeeding women. Effects on ability to drive and use machines No studies on the effects on the ability to drive and use machines have been performed. Undesirable effects Hypersensitive reactions (local rash, contact dermatitis, eczema and angioedema of the lips) may occur. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified healthcare practitioner should be consulted. Overdose No case of overdose has been reported. COMMUNITY LIST ENTRY ON ELEUTHEROCOCCUS SENTICOSUS (RUPR. ET MAXIM.) MAXIM., RADIX Scientific name of the plant Eleutherococcus senticosus (Rupr. et Maxim.) Maxim. Botanical family Araliaceae Herbal substance Eleutherococcus root Common name in all EU official languages of herbal substance   BG (bălgarski): елеутерокок, корен   CS (čeština): eleuterokokový kořen   DA (dansk): Russisk rod   DE (Deutsch): Taigawurzel   EL (elliniká): Pίζα Eλευθεροκόκκου   EN (English): Eleutherococcus root   ES (español): Eleuterococo, raíz de   ET (eesti keel): eleuterokokijuur   FI (suomi): venäjänjuuren juuri   FR (français): racine d’éleuthérocoque (racine de ginseng sibérien)   HU (magyar): Szibériai ginszeng gyökér (tajga gyökér)   IT (italiano): Eleuterococco radice   LT (lietuvių kalba): Eleuterokokų šaknys   LV (latviešu valoda): Eleiterokoka sakne   MT (malti): Għerq ta’ l-elewterokokku   NL (nederlands): Russische ginsengwortel   PL (polski): korzeń eleuterokoka   PT (português): Raiz de Ginseng Siberiano   RO (română): Rădăcină de ginseng siberian   SK (slovenčina): Všehojovcový koreň   SL (slovenščina): korenina elevterokoka   SV (svenska): Rysk rot   IS (íslenska): Síberíu ginseng, rót   NO (norsk): Russisk rot Herbal preparation(s) Comminuted herbal substance for preparation of a herbal tea Liquid extract (1:1, ethanol 30-40 % v/v) Dry extract (13-25: 1, ethanol 28-40 % v/v) Dry extract (17-30: 1, ethanol 70 % v/v) Dry aqueous extract (15-17:1) Tincture (1:5, ethanol 40 % v/v) European Pharmacopoeia monograph reference Eleutherococcus — Eleutherococci radix (ref.: 01/2008: 1419 corrected 6.0) Indication(s) Traditional herbal medicinal product for symptoms of asthenia such as fatigue and weakness. The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition Chinese, European. Specified strength Not applicable. Specified posology Adolescents over 12 years of age, adults, elderly Herbal preparations. Daily dose. Comminuted herbal substance as herbal tea: 0,5-4 g. Tea preparation: 0,5 to 4 g of comminuted herbal substance for infusion in 150 ml of boiling water. Dosage frequency: 150 ml of tea infusion should be divided in one to three doses taken during the day. Liquid extract: 2-3 ml. Dry extracts (ethanol 28-70 % v/v) corresponding to 0,5-4 g dried root. Dry aqueous extract (15-17:1): 90-180 mg. Tincture: 10-15 ml. The daily dose can be taken in one to three doses. The use is not recommended in children under 12 years of age (see below “Special warnings and precautions for use”). Route of administration Oral use. Duration of use or any restrictions on the duration of use Not to be taken for more than 2 months. If the symptoms persist for more than 2 weeks during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted. Any other information necessary for the safe use Contra-indications Hypersensitivity to the active substance. Arterial hypertension. Special warnings and precautions for use The use in children under 12 years of age is not recommended because sufficient experience is not available. If the symptoms worsen during the use of the medicinal product, a doctor or a qualified healthcare practitioner should be consulted. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects Insomnia, irritability, tachycardia and headaches may occur. The frequency is not known. Overdose No case of overdose has been reported.’

Other acts of the same type
Commission Implementing Decision of 10 October 2018 laying down the final import response on behalf of the Union concerning the future import of certain chemicals pursuant to Regulation (EU) No 649/2012 of the European Parliament and of the Council and amending Commission Implementing Decision C(2016) 747Commission Implementing Decision (EU) 2018/1521 of 10 October 2018 amending Decision 2009/11/EC authorising methods for grading pig carcasses in Spain (notified under document C(2018) 6507)Council Decision (EU) 2018/1518 of 9 October 2018 amending Decision 1999/70/EC concerning the external auditors of the national central banks, as regards the external auditors of Banco de EspañaCommission Decision (EU) 2018/1520 of 9 October 2018 repealing Delegated Regulation (EU) No 1268/2012 on the rules of application of Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council on the financial rules applicable to the general budget of the UnionCouncil Decision (EU) 2018/1536 of 9 October 2018 establishing the position to be taken on behalf of the European Union within the Committee on Government Procurement on the accession of Australia to the Revised Agreement on Government ProcurementCommission Decision (EU) 2019/1127 of 4 October 2018 on the State aid SA.45359 — 2017/C (ex 2016/N) which Slovakia is planning to implement for Jaguar Land Rover Slovakia s.r.o. (notified under document C(2018) 6545) (Text with EEA relevance.)Commission Implementing Decision (EU) 2018/1478 of 3 October 2018 amending Implementing Decision (EU) 2016/2323 to update the European List of ship recycling facilities established pursuant to Regulation (EU) No 1257/2013 of the European Parliament and of the Council (Text with EEA relevance.)Commission Implementing Decision (EU) 2018/1479 of 3 October 2018 postponing the expiry date of approval of sulfuryl fluoride for use in biocidal products of product-type 8 (Text with EEA relevance.)Commission Implementing Decision (EU) 2018/1477 of 2 October 2018 on the terms and conditions of the authorisations of biocidal products containing ethyl butylacetylaminopropionate referred by Belgium in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2018) 6291) (Text with EEA relevance.)Council Implementing Decision (EU) 2018/1487 of 2 October 2018 amending Implementing Decision 2009/1013/EU authorising the Republic of Austria to continue to apply a measure derogating from Articles 168 and 168a of Directive 2006/112/EC on the common system of value added taxCouncil Implementing Decision (EU) 2018/1493 of 2 October 2018 authorising Hungary to introduce a special measure derogating from point (a) of Article 26(1) and Articles 168 and 168a of Directive 2006/112/EC on the common system of value added taxDecision (EU) 2018/1675 of the European Parliament and of the Council of 2 October 2018 on the mobilisation of the European Globalisation Adjustment Fund following an application from the Netherlands — EGF/2018/001 NL/Financial service activities

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next